Tackling cardiovascular diseases with a new generation of polypills
CHANNEL
Topic: Risk Factors and Prevention – Epidemiology
Session type: Industry Q&A session
Date: Time:* -

See more details
Watch Replay
Chairperson
Charalambos Vlachopoulos (Athens, Greece)
Subtitle
Sponsored by SERVIER
Learning objectives
Dyslipidemia and hypertension are the most important risks factors of cardiovascular diseases The more frequent use of a new generation of polypills is the best way to optimize adherence to treatment and thus prognosis in cardiovascular patients
Presentations
Introduction.
Speaker: Charalambos Vlachopoulos (Athens, Greece)
Time:

Benefits of controlling both blood pressure and LDL-cholesterol in terms of cardiovascular protection.
Speaker: Bryan Williams (London, United Kingdom of Great Britain & Northern Ireland)
Time:

From pathophysiology to clinical benefits: what new combinations of a statin and antihypertensive drugs can provide.
Speaker: Claudio Borghi (Bologna, Italy)
Time:

Questions and Answers.
Time:

Conclusion.
Speaker: Charalambos Vlachopoulos (Athens, Greece)
Time: